Screener
Mirum Pharmaceuticals, Inc. MIRM Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s total equity?
- Mirum Pharmaceuticals, Inc. (MIRM) reported total equity of -$10.42M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s total equity changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s total equity decreased by 104.1% year-over-year, from $255.16M to -$10.42M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s total equity?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s total equity has grown at a 12.8% compound annual growth rate (CAGR), from $172.1M to $314.69M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Mirum Pharmaceuticals, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude